Current role
Biotechnology · Healthcare
Chief Accounting Officer
2024-06-05–present
Annie Yoshiyama
Chief Accounting Officer
Allogene Therapeutics, Inc. (ALLO)Equibles does not estimate personal net worth.
Get an email with a short summary when Allogene Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ALLO alertsAbout Annie Yoshiyama
Annie Yoshiyama is recorded as Chief Accounting Officer at Allogene Therapeutics, Inc. (ALLO) since June 5, 2024. Allogene Therapeutics, Inc. reported in an 8-K filed June 10, 2024 that Annie Yoshiyama was appointed principal accounting officer, effective June 5, 2024. Allogene Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Allogene Therapeutics, Inc. includes Zachary Roberts, M.D., Ph.D. (CEO and Board Member), Geoffrey Parker (CFO), Tim Moore (CTO) and 4 others.
“On June 5, 2024, the Board of Directors of Allogene Therapeutics, Inc. (the "Company") appointed Annie Yoshiyama, the Company's current Senior Vice President and Corporate Controller, as the Company's principal accounting officer, effective immediately, replacing Geoffrey Parker in such capacity.”
Affiliation history
-
Current
2024-06-05–present
Company network
Leadership on record at Allogene Therapeutics, Inc.
- Zachary Roberts, M.D., Ph.D. CEO, Board Member
- Geoffrey Parker CFO
- Tim Moore CTO
- Timothy Moore CTO
- Elizabeth Barrett Board Member
- Stephen Mayo, Ph.D. Board Member
- Vicki Sato, Ph.D. Board Member